X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs AJANTA PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. AJANTA PHARMA FDC LTD./
AJANTA PHARMA
 
P/E (TTM) x 18.8 22.8 82.5% View Chart
P/BV x 3.8 4.4 86.0% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 FDC LTD.   AJANTA PHARMA
EQUITY SHARE DATA
    FDC LTD.
Mar-14
AJANTA PHARMA
Mar-18
FDC LTD./
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs1441,818 7.9%   
Low Rs791,106 7.1%   
Sales per share (Unadj.) Rs47.6239.5 19.9%  
Earnings per share (Unadj.) Rs7.652.8 14.4%  
Cash flow per share (Unadj.) Rs9.059.5 15.1%  
Dividends per share (Unadj.) Rs2.250-  
Dividend yield (eoy) %2.00-  
Book value per share (Unadj.) Rs47.5230.0 20.7%  
Shares outstanding (eoy) m177.8388.77 200.3%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.36.1 38.3%   
Avg P/E ratio x14.627.7 52.8%  
P/CF ratio (eoy) x12.324.6 50.3%  
Price / Book Value ratio x2.36.4 36.8%  
Dividend payout %29.60-   
Avg Mkt Cap Rs m19,784129,782 15.2%   
No. of employees `000NA6.8 0.0%   
Total wages/salary Rs m1,2213,765 32.4%   
Avg. sales/employee Rs ThNM3,128.4-  
Avg. wages/employee Rs ThNM554.0-  
Avg. net profit/employee Rs ThNM689.7-  
INCOME DATA
Net Sales Rs m8,45921,258 39.8%  
Other income Rs m394242 162.9%   
Total revenues Rs m8,85221,499 41.2%   
Gross profit Rs m2,0706,584 31.4%  
Depreciation Rs m249596 41.8%   
Interest Rs m314 756.3%   
Profit before tax Rs m2,1846,226 35.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6061,539 39.3%   
Profit after tax Rs m1,3534,686 28.9%  
Gross profit margin %24.531.0 79.0%  
Effective tax rate %27.724.7 112.2%   
Net profit margin %16.022.0 72.6%  
BALANCE SHEET DATA
Current assets Rs m4,35512,236 35.6%   
Current liabilities Rs m1,7923,461 51.8%   
Net working cap to sales %30.341.3 73.4%  
Current ratio x2.43.5 68.7%  
Inventory Days Days4460 73.8%  
Debtors Days Days2584 29.2%  
Net fixed assets Rs m3,02511,140 27.2%   
Share capital Rs m179177 101.0%   
"Free" reserves Rs m8,24320,237 40.7%   
Net worth Rs m8,45320,414 41.4%   
Long term debt Rs m1110 105.9%   
Total assets Rs m10,55724,486 43.1%  
Interest coverage x71.41,519.4 4.7%   
Debt to equity ratio x00 255.8%  
Sales to assets ratio x0.80.9 92.3%   
Return on assets %13.119.2 68.4%  
Return on equity %16.023.0 69.7%  
Return on capital %23.530.5 77.1%  
Exports to sales %13.30-   
Imports to sales %3.30-   
Exports (fob) Rs m1,126NA-   
Imports (cif) Rs m283NA-   
Fx inflow Rs m1,14611,667 9.8%   
Fx outflow Rs m3551,616 22.0%   
Net fx Rs m79110,052 7.9%   
CASH FLOW
From Operations Rs m1,4852,854 52.0%  
From Investments Rs m-620-2,604 23.8%  
From Financial Activity Rs m-753-2 37,625.0%  
Net Cashflow Rs m113248 45.5%  

Share Holding

Indian Promoters % 68.9 73.8 93.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 1.6 303.2%  
FIIs % 7.5 7.6 98.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 17.0 111.8%  
Shareholders   23,730 20,968 113.2%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   ORCHID PHARMA LTD  CIPLA  TORRENT PHARMA  SUVEN LIFESCIENCES  WYETH LTD  

Compare FDC LTD. With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Marginally Higher; Realty and Energy Stocks Witness Buying(Closing)

Indian share markets witnessed volatility during closing hours and ended their day marginally higher. Gains were largely seen in the realty sector.

Related Views on News

FDC LTD. Announces Quarterly Results (3QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Feb 15, 2019 | Updated on Feb 15, 2019

For the quarter ended December 2018, FDC LTD. has posted a net profit of Rs 437 m (up 2.5% YoY). Sales on the other hand came in at Rs 3 bn (up 1.4% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

AJANTA PHARMA Announces Quarterly Results (3QFY19); Net Profit Down 54.6% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, AJANTA PHARMA has posted a net profit of Rs 669 m (down 54.6% YoY). Sales on the other hand came in at Rs 5 bn (down 17.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

FDC LTD. Announces Quarterly Results (2QFY19); Net Profit Down 33.6% (Quarterly Result Update)

Nov 23, 2018 | Updated on Nov 23, 2018

For the quarter ended September 2018, FDC LTD. has posted a net profit of Rs 431 m (down 33.6% YoY). Sales on the other hand came in at Rs 3 bn (down 12.0% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 4.9% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, AJANTA PHARMA has posted a net profit of Rs 1 bn (down 4.9% YoY). Sales on the other hand came in at Rs 5 bn (up 0.7% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

FDC LTD. Announces Quarterly Results (1QFY19); Net Profit Up 74.5% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, FDC LTD. has posted a net profit of Rs 511 m (up 74.5% YoY). Sales on the other hand came in at Rs 3 bn (up 16.7% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

More Views on News

Most Popular

Are You Ready for the Big Nifty Move in the March Expiry?(Profit Hunter)

Mar 8, 2019

History suggests the Nifty could make a big move in March. Are you prepared to benefit from this opportunity?

Smallcaps Are Rallying and You Need to Make the Most of It Now(Profit Hunter)

Mar 7, 2019

Did you just miss the smallcap rally? Or is there still time to catch up? Read on for answers and more...

The One Sector to Bet on Today as India Grows into a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Mar 7, 2019

India's defence sector is suddenly under the spotlight. Can this sector ride along India's long-term growth story?

Is it the Right Time to Buy Mid and Small Caps Now?(The 5 Minute Wrapup)

Mar 6, 2019

Mid and Small Caps have underperformed large caps in the past year. Is the tide about to turn?

The Jet Airways Crisis in 6 Charts(Sector Info)

Mar 5, 2019

What happened to Jet Airways, once among top 3 airlines in India? Is it another Kingfisher in the making? Read on...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Mar 18, 2019 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. 8-QTR ANALYSIS

COMPARE FDC LTD. WITH

MARKET STATS